Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Andrews

Showing results (151-160 of 364) with videos related to

Pageof 37
Sort By:
Vaccine|March 23, 2005
Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine in toddlers and school childrenJamie Findlow, Ann Lowe, Sarah Deane, et al.
Plos Medicine|April 13, 2011
Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional studyStefan Flasche, Albert Jan Van Hoek, Elizabeth Sheasby, et al.
Clinical and Vaccine Immunology : CVI|September 21, 2007
Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccinePaul Balmer, Ray Borrow, Jamie Findlow, et al.
Plos One|October 25, 2011
7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement?Yoon Hong Choi, Mark Jit, Nigel Gay, et al.
Vaccine|December 21, 2016
Rabies pre-exposure prophylaxis elicits long-lasting immunity in humansKaren L Mansfield, Nick Andrews, Hooman Goharriz, et al.
Health Informatics Journal|January 21, 2014
Development and refinement of new statistical methods for enhanced syndromic surveillance during the 2012 Olympic and Paralympic GamesRoger A Morbey, Alex J Elliot, Andre Charlett, et al.
Clinical and Vaccine Immunology : CVI|May 15, 2007
Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in EnglandCaroline Trotter, Jamie Findlow, Paul Balmer, et al.
Journal of Medical Microbiology|December 4, 2023
Mixture modelling of <i>Bordetella pertussis</i> serology samples to evaluate anti-pertussis toxin immunoglobulin G titre thresholds for positivity: England 2008-2022Elise Tessier, David Litt, Sonia Ribeiro, et al.
The Journal of Infectious Diseases|October 29, 2002
Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United kingdomRay Borrow, David Goldblatt, Nick Andrews, et al.
The Lancet. Infectious Diseases|November 27, 2022
Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control studyAnnabel A Powell, Freja Kirsebom, Julia Stowe, et al.
Pageof 37

Showing results (151-160 of 364) with videos related to

Sort By:
Pageof 37
Vaccine|March 23, 2005
Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine in toddlers and school childrenJamie Findlow, Ann Lowe, Sarah Deane, et al.
Plos Medicine|April 13, 2011
Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional studyStefan Flasche, Albert Jan Van Hoek, Elizabeth Sheasby, et al.
Clinical and Vaccine Immunology : CVI|September 21, 2007
Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccinePaul Balmer, Ray Borrow, Jamie Findlow, et al.
Plos One|October 25, 2011
7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement?Yoon Hong Choi, Mark Jit, Nigel Gay, et al.
Vaccine|December 21, 2016
Rabies pre-exposure prophylaxis elicits long-lasting immunity in humansKaren L Mansfield, Nick Andrews, Hooman Goharriz, et al.
Health Informatics Journal|January 21, 2014
Development and refinement of new statistical methods for enhanced syndromic surveillance during the 2012 Olympic and Paralympic GamesRoger A Morbey, Alex J Elliot, Andre Charlett, et al.
Clinical and Vaccine Immunology : CVI|May 15, 2007
Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in EnglandCaroline Trotter, Jamie Findlow, Paul Balmer, et al.
Journal of Medical Microbiology|December 4, 2023
Mixture modelling of <i>Bordetella pertussis</i> serology samples to evaluate anti-pertussis toxin immunoglobulin G titre thresholds for positivity: England 2008-2022Elise Tessier, David Litt, Sonia Ribeiro, et al.
The Journal of Infectious Diseases|October 29, 2002
Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United kingdomRay Borrow, David Goldblatt, Nick Andrews, et al.
The Lancet. Infectious Diseases|November 27, 2022
Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control studyAnnabel A Powell, Freja Kirsebom, Julia Stowe, et al.
Pageof 37